---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-004461"
form_type: "8-K"
ticker: "MTVA"
cik: "0001638287"
company_name: "MetaVia Inc."
filed_at: "2023-01-18T23:59:59+00:00"
generated_at: "2026-06-20T14:04:51.946820+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NeuroBo CEO Gil Price resigns; Joseph Hooker named Interim CEO

## Summary
- Gil Price resigned as CEO and President effective Jan 12, 2023; resignation not due to disagreement.
- Joseph Hooker appointed Interim CEO, President, and Principal Financial and Accounting Officer.
- Hooker brings ~40 years pharma experience; previously at X4 Pharma, Biogen, Novartis.
- Board to initiate permanent CEO search with executive search firm.
- Company advancing DA-1241 and DA-1726; completed $32.3M financing in Nov 2022.

## SEC filing metadata
- accession: 0001104659-23-004461
- form_type: 8-K
- ticker: MTVA
- cik: 0001638287
- company_name: MetaVia Inc.
- filed_at: 2023-01-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638287/000110465923004461/0001104659-23-004461-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638287/000110465923004461/tm233671d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-004461
- JSON: https://secwatch.observer/filing/0001104659-23-004461.json
- Plain text: https://secwatch.observer/filing/0001104659-23-004461.txt

## Key facts
- Executive change
  Joseph Hooker was appointed as Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at MetaVia Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
  source text: On January 12, 2023, the Board appointed Joseph Hooker as the Company’s Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, effective as of January 12 , 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638287/000110465923004461/0001104659-23-004461-index.htm
- Executive change
  Gil Price resigned as Chief Executive Officer and President at MetaVia Inc..
  - Action: resigned
  - Role: Chief Executive Officer and President
  source text: On January 12, 2023, Gil Price, M.D. resigned as Chief Executive Officer and President of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company” ), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638287/000110465923004461/0001104659-23-004461-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.